Bookmark and Share

Compound Summary for: CID 11167602

regorafenib

Also known as: 755037-03-7, BAY 73-4506, Regorafenibum, Stivarga, UNII-24T2A1DOYB, BAY73-4506, CHEMBL1946170, CHEBI:68647
Molecular Formula: C21H15ClF4N4O3   Molecular Weight: 482.815413   InChIKey: FNHKPVJBJVTLMP-UHFFFAOYSA-N
Regorafenib is an orally-administered inhibitor of multiple kinases. It is used for the treatment of metastatic colorectal cancer and advanced gastrointestinal stromal tumours. FDA approved on September 27, 2012.    From: DrugBank
Show subcontent titlesTable of Contents
Identification
Related Records
show all 3 sub-sections (Related Compounds with Annotation, Related Compounds, Related Substances)
Use and Manufacturing
Literature
Patents
Biomolecular Interactions and Pathways
Biological Test Results
Classification
Chemical and Physical Properties
_ _